Drug: NEVIRAPINE. Injury: Foetal exposure during pregnancy Quarter: 2016Q3
Total Records: 35 Number of Pages: 2
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 126282221 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126282491 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126282571 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126282591 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126282621 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126282771 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126283311 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126283671 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126396041 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160810 | CA | |
| 126894951 | NEVIRAPINE. | Foetal exposure during pregnancy | ROCHE | 0.00 | 0 | 20160826 | US | |
| 127362581 | NEVIRAPINE. | Foetal exposure during pregnancy | AUROBINDO | 0.00 | 0 | 20160913 | GB | |
| 127451332 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160915 | US | |
| 127451412 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160915 | US | |
| 127459241 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160915 | US | |
| 127460651 | NEVIRAPINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160915 | US |
Total Records: 35 Number of Pages: 2